选择性5-羟色胺再摄取抑制剂通过激活NF-κB通路加重抑郁相关干眼
研究纳入20例抑郁伴干眼患者接受SSRI治疗、20例接受安慰剂,并建立大鼠抑郁模型及人角膜上皮细胞实验。结果显示SSRI组泪液5-羟色胺水平更高、眼表炎症和细胞凋亡更重;SSRI通过升高泪液5-羟色胺激活NF-κB信号加重干眼,HTR拮抗剂或NF-κB抑制剂可能成为治疗策略。
要点
- SSRI组泪液5-羟色胺水平更高,眼表炎症和细胞凋亡更严重。
- SSRI通过升高泪液5-羟色胺加重抑郁相关干眼并破坏角膜上皮屏障。
- 5-羟色胺通过激活NF-κB信号诱导角膜上皮细胞炎症和凋亡。
核心结论
- SSRI通过激活NF-κB通路加重抑郁相关干眼。
- HTR拮抗剂或NF-κB信号抑制剂是抑郁相关干眼的潜在治疗策略。
研究设计与样本
- 20例抑郁伴干眼患者随机接受SSRI治疗,另20例接受安慰剂治疗。
- 建立大鼠抑郁模型并应用SSRI 3或6周。
- 人角膜上皮细胞接受5-羟色胺、HTR拮抗剂和/或NF-κB信号抑制剂处理。
主要发现
- SSRI组泪液5-羟色胺水平更高,眼表炎症和细胞凋亡更严重。
- 大鼠抑郁模型抑郁降低泪液分泌并增加IL-1β和TNF-α产生,而5-羟色胺、TLR2和TLR4水平未升高。
- SSRI通过增加泪液5-羟色胺加重干眼、破坏角膜上皮屏障并促进眼表炎症反应。
- 5-羟色胺通过激活NF-κB信号诱导角膜上皮细胞炎症反应和细胞凋亡。
临床怎么用
- 抑郁患者使用SSRI时需关注干眼加重风险。
- HTR拮抗剂或NF-κB信号抑制剂可能用于抑郁相关干眼的治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our study aimed to evaluate the side effects of selective serotonin reuptake inhibitors (SSRIs) on the ocular surface. METHODS: Twenty patients with depression and dry eye disease (DED) were randomly picked to receive SSRI treatment, whereas another 20 patients received placebo treatment. The serotonin, inflammatory cytokine, and proapoptotic protein levels were determined by using protein chip, qRT-PCR, and ELISA analyses. A rat depression model was established, and SSRIs were applied for 3 or 6 weeks. Tear production and corneal epithelial barrier function were evaluated. The serotonin and inflammatory cytokine levels were analyzed by qRT-PCR, immunohistochemical staining, and ELISA. Human corneal epithelial cells were subjected to serotonin, a HTR antagonist, and/or an NF-κB signaling inhibitor. The inflammatory cytokine and proapoptotic protein levels were determined by qRT-PCR, Western blot analysis, and ELISA. The cell apoptosis rate was assessed by using flow cytometry. RESULTS: The SSRI group had higher tear serotonin levels and more serious inflammation and cell apoptosis on the ocular surface. In the rat depression model, depression decreased tear secretion and increased IL-1β and TNF-α production, whereas the serotonin, TLR2, and TLR4 levels were not increased. SSRI aggravated DED, disrupted the corneal epithelial barrier, and promoted an inflammatory response on the ocular surface by increasing the tear serotonin levels. In addition, serotonin induced an inflammatory response and cell apoptosis in corneal epithelial cells by activating NF-κB signaling. CONCLUSIONS: SSRIs aggravate depression-associated DED via activating the NF-κB pathway. The antagonist of HTRs or the inhibitor of NF-κB signaling presents a potential therapeutic strategy for depression-associated DED. (Trial registration number, ChiCTR1800015592).
引用
- Zhang X, Yin Y, Yue L, et al. Selective Serotonin Reuptake Inhibitors Aggravate Depression-Associated Dry Eye Via Activating the NF-κB Pathway. Invest Ophthalmol Vis Sci. 2019. PMID: 30695093. doi:10.1167/iovs.18-25572
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。